Robert Engler
Directeur/Membre du Conseil chez GlySens, Inc.
Profil
Robert L.
Engler is the founder of Collateral Therapeutics, Inc. (1995).
He held the title of Director from 1995 to 2000.
Dr. Engler is also the founder of SICOR, Inc., Gensia Pharmaceuticals, Inc., Veterans Medical Research Foundation of San Diego.
Currently, Dr. Engler is a Director at GlySens, Inc. and a Member at American Society of Clinical Oncology, Inc. Dr. Engler's former positions include Independent Director at Halozyme Therapeutics, Inc. (2011-2015), Director at Verdezyne, Inc., Professor-Emeritus at the University of California San Diego, Principal at US Department of Veterans Affairs (West Virginia), and Member at American Association for Cancer Research.
Dr. Engler received a doctorate from Georgetown University and an undergraduate degree from The University of North Carolina at Charlotte.
Postes actifs de Robert Engler
| Sociétés | Poste | Début |
|---|---|---|
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
GlySens, Inc.
 GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Engler
| Sociétés | Poste | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2015 |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Fondateur | 01/10/2007 |
| University of California San Diego | Corporate Officer/Principal | 01/01/2001 |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Fondateur | 01/01/2000 |
| US Department of Veterans Affairs (West Virginia) | Corporate Officer/Principal | - |
Formation de Robert Engler
| Georgetown University | Doctorate Degree |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Commercial Services |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Health Technology |
Verdezyne, Inc.
 Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Health Technology |
Gensia Pharmaceuticals, Inc.
 Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Health Technology |
| US Department of Veterans Affairs (West Virginia) | Government |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Veterans Medical Research Foundation of San Diego
 Veterans Medical Research Foundation of San Diego Investment Trusts/Mutual FundsMiscellaneous Veterans Medical Research Foundation of San Diego functions as a foundation or endowment. The non-profit company is based in San Diego, CA. The company was founded by Robert L. Engler. Maria Sittmann has been the CEO of the company since 2004. | Miscellaneous |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Health Technology |
